In re Mirena IUS Levonorgestrel-Related Products Liability Litigation

ORDER DENYING TRANSFER

JOHN G. HEYBURN II, Chairman.

Before the Panel:* Pursuant to 28 U.S.C. § 1407, plaintiffs in all actions move to centralize this litigation in the Middle District of Tennessee or, alternatively, the Northern District of Alabama or the Western District of Kentucky. The litigation consists of nine actions pending in six districts, as listed on Schedule A.1 Defendant Bayer Healthcare Pharmaceuticals, Inc. (“Bayer”) opposes centralization and, in the alternative, requests the Southern District of New York.

Some characteristics of this litigation suggest that it would benefit…